Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: Perioperative Tranexamic Acid in Melanoma
NCT05899465Phase 3Recruiting
- Sponsor
- Aarhus University
- Start
- Aug 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in melanoma, sponsored by Aarhus University. Started Aug 2023; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT05899465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05899465.